169 related articles for article (PubMed ID: 12679839)
1. The role of 24S-hydroxycholesterol in Alzheimer's disease.
Kölsch H; Lütjohann D; von Bergmann K; Heun R
J Nutr Health Aging; 2003; 7(1):37-41. PubMed ID: 12679839
[TBL] [Abstract][Full Text] [Related]
2. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism.
Lütjohann D; von Bergmann K
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S102-6. PubMed ID: 14574622
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's disease.
Lukiw WJ
Expert Rev Neurother; 2006 May; 6(5):683-93. PubMed ID: 16734516
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease.
Reiss AB; Siller KA; Rahman MM; Chan ES; Ghiso J; de Leon MJ
Neurobiol Aging; 2004 Sep; 25(8):977-89. PubMed ID: 15212822
[TBL] [Abstract][Full Text] [Related]
5. PPARD haplotype influences cholesterol metabolism but is no risk factor of Alzheimer's disease.
Holzapfel J; Heun R; Lütjohann D; Jessen F; Maier W; Kölsch H
Neurosci Lett; 2006 Nov; 408(1):57-61. PubMed ID: 16979821
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease.
Kölsch H; Lütjohann D; Ludwig M; Schulte A; Ptok U; Jessen F; von Bergmann K; Rao ML; Maier W; Heun R
Mol Psychiatry; 2002; 7(8):899-902. PubMed ID: 12232784
[TBL] [Abstract][Full Text] [Related]
7. CETP polymorphisms influence cholesterol metabolism but not Alzheimer's disease risk.
Qureischie H; Heun R; Lütjohann D; Popp J; Jessen F; Ledschbor-Frahnert C; Thiele H; Maier W; Hentschel F; Kelemen P; Kölsch H
Brain Res; 2008 Sep; 1232():1-6. PubMed ID: 18680734
[TBL] [Abstract][Full Text] [Related]
8. Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease.
Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Rao ML; Maier W; Björkhem I; von Bergmann K; Heun R
Neuroreport; 2000 Jun; 11(9):1959-62. PubMed ID: 10884051
[TBL] [Abstract][Full Text] [Related]
9. Influence of lysosomal acid lipase polymorphisms on chromosome 10 on the risk of Alzheimer's disease and cholesterol metabolism.
von Trotha KT; Heun R; Schmitz S; Lütjohann D; Maier W; Kölsch H
Neurosci Lett; 2006 Jul; 402(3):262-6. PubMed ID: 16730122
[TBL] [Abstract][Full Text] [Related]
10. Oxysterols as markers of neurological disease--a review.
Leoni V
Scand J Clin Lab Invest; 2009; 69(1):22-5. PubMed ID: 19199127
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of 24S-hydroxycholesterol in neuronal SK-N-BE cells treated with hexacosanoic acid (C26:0): argument in favor of 24S-hydroxycholesterol as a potential biomarker of neurolipotoxicity.
Zarrouk A; Hammami M; Moreau T; Lizard G
Rev Neurol (Paris); 2015 Feb; 171(2):125-9. PubMed ID: 25577946
[TBL] [Abstract][Full Text] [Related]
12. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease.
Heverin M; Bogdanovic N; Lütjohann D; Bayer T; Pikuleva I; Bretillon L; Diczfalusy U; Winblad B; Björkhem I
J Lipid Res; 2004 Jan; 45(1):186-93. PubMed ID: 14523054
[TBL] [Abstract][Full Text] [Related]
13. Oxysterols and Alzheimer's disease.
Björkhem I; Heverin M; Leoni V; Meaney S; Diczfalusy U
Acta Neurol Scand Suppl; 2006; 185():43-9. PubMed ID: 16866910
[TBL] [Abstract][Full Text] [Related]
14. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.
Vega GL; Weiner MF; Lipton AM; Von Bergmann K; Lutjohann D; Moore C; Svetlik D
Arch Neurol; 2003 Apr; 60(4):510-5. PubMed ID: 12707064
[TBL] [Abstract][Full Text] [Related]
15. Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's disease.
Popp J; Meichsner S; Kölsch H; Lewczuk P; Maier W; Kornhuber J; Jessen F; Lütjohann D
Biochem Pharmacol; 2013 Jul; 86(1):37-42. PubMed ID: 23291240
[TBL] [Abstract][Full Text] [Related]
16. Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients.
Sauder S; Kölsch H; Lütjohann D; Schulz A; von Bergmann K; Maier W; Heun R
J Neural Transm (Vienna); 2005 Oct; 112(10):1381-9. PubMed ID: 15666037
[TBL] [Abstract][Full Text] [Related]
17. The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins.
Vega GL; Weiner M; Kölsch H; von Bergmann K; Heun R; Lutjohan D; Nguyen A; Moore C
Curr Alzheimer Res; 2004 Feb; 1(1):71-7. PubMed ID: 15975088
[TBL] [Abstract][Full Text] [Related]
18. Lipid metabolism in cognitive decline and dementia.
Panza F; D'Introno A; Colacicco AM; Capurso C; Pichichero G; Capurso SA; Capurso A; Solfrizzi V
Brain Res Rev; 2006 Aug; 51(2):275-92. PubMed ID: 16410024
[TBL] [Abstract][Full Text] [Related]
19. Oxysterols and neurodegenerative diseases.
Björkhem I; Cedazo-Minguez A; Leoni V; Meaney S
Mol Aspects Med; 2009 Jun; 30(3):171-9. PubMed ID: 19248803
[TBL] [Abstract][Full Text] [Related]
20. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.
Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Buschfort R; Ptok U; Björkhem I; von Bergmann K; Heun R
J Psychiatr Res; 2002; 36(1):27-32. PubMed ID: 11755458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
